Kevin Caliendo
Stock Analyst at UBS
(4.55)
# 224
Out of 5,154 analysts
207
Total ratings
72.82%
Success rate
12.38%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Buy | $10 → $5 | $3.17 | +57.73% | 4 | Feb 26, 2026 | |
| MDLN Medline | Maintains: Buy | $48 → $57 | $43.83 | +30.05% | 2 | Feb 26, 2026 | |
| LFST LifeStance Health Group | Maintains: Buy | $10 → $12 | $6.93 | +73.16% | 7 | Feb 26, 2026 | |
| HSIC Henry Schein | Maintains: Neutral | $79 → $87 | $77.60 | +12.11% | 7 | Feb 25, 2026 | |
| DGX Quest Diagnostics | Maintains: Neutral | $190 → $210 | $199.21 | +5.42% | 17 | Feb 11, 2026 | |
| ALGN Align Technology | Maintains: Neutral | $175 → $185 | $174.00 | +6.32% | 20 | Feb 5, 2026 | |
| XRAY DENTSPLY SIRONA | Maintains: Buy | $17 → $16 | $12.74 | +25.59% | 13 | Feb 3, 2026 | |
| NVST Envista Holdings | Maintains: Neutral | $22 → $25 | $26.86 | -6.92% | 5 | Feb 3, 2026 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $18 → $21 | $18.44 | +13.88% | 9 | Jan 14, 2026 | |
| CVS CVS Health | Maintains: Buy | $96 → $97 | $77.92 | +24.49% | 11 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $77 → $79 | $69.41 | +13.82% | 2 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $380 → $415 | $358.46 | +15.77% | 4 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.25 → $4 | $2.28 | +75.44% | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $920 → $980 | $919.26 | +6.61% | 17 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $220 | $217.78 | +1.02% | 18 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $378 → $430 | $286.48 | +50.10% | 13 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $320 | $269.67 | +18.66% | 7 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $144.47 | +17.67% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $9 | $5.46 | +64.84% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $271.63 | +43.58% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $179.15 | +39.55% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $43.65 | +80.99% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $289.64 | +98.52% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $240.40 | -25.12% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $5.08 | +1,317.32% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $31.05 | -64.57% | 4 | May 4, 2021 |
Evolent Health
Feb 26, 2026
Maintains: Buy
Price Target: $10 → $5
Current: $3.17
Upside: +57.73%
Medline
Feb 26, 2026
Maintains: Buy
Price Target: $48 → $57
Current: $43.83
Upside: +30.05%
LifeStance Health Group
Feb 26, 2026
Maintains: Buy
Price Target: $10 → $12
Current: $6.93
Upside: +73.16%
Henry Schein
Feb 25, 2026
Maintains: Neutral
Price Target: $79 → $87
Current: $77.60
Upside: +12.11%
Quest Diagnostics
Feb 11, 2026
Maintains: Neutral
Price Target: $190 → $210
Current: $199.21
Upside: +5.42%
Align Technology
Feb 5, 2026
Maintains: Neutral
Price Target: $175 → $185
Current: $174.00
Upside: +6.32%
DENTSPLY SIRONA
Feb 3, 2026
Maintains: Buy
Price Target: $17 → $16
Current: $12.74
Upside: +25.59%
Envista Holdings
Feb 3, 2026
Maintains: Neutral
Price Target: $22 → $25
Current: $26.86
Upside: -6.92%
Alignment Healthcare
Jan 14, 2026
Maintains: Neutral
Price Target: $18 → $21
Current: $18.44
Upside: +13.88%
CVS Health
Dec 10, 2025
Maintains: Buy
Price Target: $96 → $97
Current: $77.92
Upside: +24.49%
Nov 10, 2025
Maintains: Neutral
Price Target: $77 → $79
Current: $69.41
Upside: +13.82%
Nov 7, 2025
Maintains: Buy
Price Target: $380 → $415
Current: $358.46
Upside: +15.77%
Nov 6, 2025
Maintains: Neutral
Price Target: $4.25 → $4
Current: $2.28
Upside: +75.44%
Nov 6, 2025
Maintains: Buy
Price Target: $920 → $980
Current: $919.26
Upside: +6.61%
Oct 31, 2025
Maintains: Buy
Price Target: $185 → $220
Current: $217.78
Upside: +1.02%
Oct 29, 2025
Maintains: Buy
Price Target: $378 → $430
Current: $286.48
Upside: +50.10%
Oct 29, 2025
Maintains: Buy
Price Target: $325 → $320
Current: $269.67
Upside: +18.66%
Oct 24, 2025
Maintains: Neutral
Price Target: $180 → $170
Current: $144.47
Upside: +17.67%
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $5.46
Upside: +64.84%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $271.63
Upside: +43.58%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $179.15
Upside: +39.55%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $43.65
Upside: +80.99%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $289.64
Upside: +98.52%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $240.40
Upside: -25.12%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $5.08
Upside: +1,317.32%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $31.05
Upside: -64.57%